Phlebolymphology N°109 – Editorial
In this new issue of Phlebolymphology, you will find the articles as below:
Hypodermitis or lipodermatosclerosis (LDS) is a chronic inflammatory process of the dermis and subcutaneous layer in the legs of patients with advanced chronic venous disease (CVD). It is one of the clinical findings for class C4b in the CEAP classification (clinical, etiological, anatomical, and pathophysiological) of CVD; however, the cellular and molecular mechanisms responsible for progression of CVD and development of LDS remain unclear. L. REINA-GUTIERREZ and A. SANJUANBENITO-REINA (Spain), provide an up-to-date review on the epidemiology, pathophysiology, clinical manifestations, and management of hypodermitis or LDS.
Acute iliofemoral deep vein thrombosis is more symptomatic than a thrombosis distal to the common femoral vein and increases the risk of postthrombotic syndrome, which reduces quality of life and increases medical costs. To provide the best possible medical care, it all starts with identifying iliofemoral deep vein thrombosis. M. J. E. VAN RIJN and J. M. BAKAS (Netherlands) discuss the challenges, opportunities, and future perspectives for the treatment of iliofemoral deep vein thrombosis.
K. OZSVATH (USA) presents a literature review on the use of cyanoacrylate preparations – eg, VenaSeal, VenaBlock, and VariClose – within the venous system, preparations frequently used in the management of venous disorders; possible complications are also addressed.
A. JAWORUCKA-KACZOROWSKA (Poland) summarizes the potential etiologies of chronic pelvic pain (CPP) with a primary focus on gynecological issues, including pelvic venous disorders (PeVDs), an entity at the interface between gynecology and vascular surgery and an increasingly recognizable pathology.
Limited data are available on the prevalence of varicose veins and on risk factors for varicose veins during pregnancy. S. D. AKSOY and colleagues (Turkey) present the results of a recent observational study that was conducted to estimate the prevalence of varicose veins, identify the associated risk factors, and assess the impact on quality of life from varicose vein presence in pregnancy
Enjoy reading this issue!
Dr. H. Pelin Yaltirik